Board of Directors

Biography PhotoWilliam G.  Rice, Ph.D.
Chairman of the Board
Dr. Rice serves as the Chairman, President and Chief Executive Officer of Aptose. Through a blend of leadership roles in industry, government, and academic sectors, Dr. Rice has accrued more than 25 years of know-how and forged a diverse set of executive, operational, business development, financial, and product research and development skills. Prior to joining Aptose, Dr. Rice served as the President, Chief Executive Officer and Chairman of the Board of Cylene Pharmaceuticals, Inc. In that role he led the strategic, financing, and business development activities resulting in the development and sale of small molecule therapeutic programs designed to exploit CK2-driven pathways and non-genotoxic mechanisms for activating p53 to kill cancer cells. Before Cylene, Dr. Rice was the Founder, President, Chief Executive Officer and Director of Achillion Pharmaceuticals, Inc. He also served as Senior Scientist and Head of the Drug Mechanism Laboratory at the National Cancer Institute-Frederick Cancer Research and Development Center, and served as a faculty member in the division of Pediatric Hematology and Oncology at Emory University School of Medicine. Dr. Rice holds a Ph.D. in biochemistry from Emory University and was a post-doctoral trainee in the Department of Internal Medicine at the University of Michigan Medical Center. At the R&D level, Dr. Rice has identified multiple new molecular drug targets, delivered multiple first-in-class drugs to the clinic, and published peer-reviewed findings in Science, Nature, Cancer Cell, Nature Medicine, Proceedings of the National Academy of Sciences and other prestigious journals. Within the industry sector, he has built two biotech companies, received biotech achievement awards, negotiated various business development deals, and executed an array of corporate financings.... read more

Biography PhotoDenis R. Burger, Ph.D.
Board Member
Dr. Burger currently is the executive Chairman of BioCurex, Inc., a company based in Richmond, Canada. Previously, he co-founded Trinity Biotech, PLC, a diagnostic biotechnology company based in Dublin, Ireland, where he was Chairman from 1992 to 1995 and now serves on its Board of Directors. Dr. Burger was the past Chairman, Chief Executive Officer and a Director of AVI Biopharma Inc., an Oregon-based biotechnology company. Dr. Burger is also a partner in Sovereign Ventures, a healthcare consulting and funding firm based in Portland, Oregon. He was a co-founder and Chairman of Epitope Inc. from 1981 to 1990. In addition, Dr. Burger has held a professorship in the Department of Microbiology and Immunology and Surgery (Surgical Oncology) at the Oregon Health Sciences University in Portland. Dr. Burger received his M.Sc. and Ph.D. in Microbiology and Immunology from the University of Arizona.... read more

Biography PhotoErich M.  Platzer, M.D., Ph.D.
Board Member
Dr. Platzer is a board certified physician in internal medicine, hematology and medical oncology. Previously, Dr. Platzer served as the business director of oncology, as well as the global strategic marketing and therapeutic area head of oncology at Roche, Basel. He was also the medical director in oncology and global development project leader and was responsible for various strategic corporate partnerships. Dr. Platzer is a director of Swiss Business Angel Groups, StartAngels and BioBAC, and has served as a pharmaceutical industry expert on the board of directors of multiple biotech companies in both the U.S. and Europe such as Probiodrug, AOT, Léman Micro Devices, Credentis, and Viroblock. Dr. Platzer co-founded and currently serves as an investment advisor to HBM Healthcare Investments (formerly HBM BioVentures), a global leader in healthcare investing. He has over 12 years of experience in academic medicine and research and was a key member of the team at MSKCC that purified human G-CSF in 1983 (recombinant form: Neupogen®). He earned his M.D. from the Medical School and the Institute of Clinical Immunology and Rheumatology of the University of Erlangen, where he also received his “Dr. med. habil.” (M.D.,Ph.D.).... read more

Biography PhotoWarren  Whitehead
Board Member
Mr. Whitehead is a Certified Management Accountant who has held senior financial management positions in several biotechnology and pharmaceutical companies. Most recently he served as Chief Financial Officer of Arius Research Inc., a biotechnology company, providing financial guidance and leadership during the acquisition of Arius by Roche in 2008. Prior to Arius, Mr. Whitehead was Chief Financial Officer at Labopharm Inc., where he completed a series of public equity financings and an initial public offering on the NASDAQ stock exchange. He currently is a member of the Board of Directors of PlantForm Corporation, a life sciences company that develops biosimilar antibody drugs for treatment of cancer and other life-threatening illnesses. Mr. Whitehead received his BA from the University of Western Ontario, and a BComm and MBA from the University of Windsor. Mr. Whitehead is also a Chartered Professional Accountant (CPA) and a Certified Management Accountant (CMA).... read more

Biography PhotoMark Vincent, M.D.
Board Member
Dr. Vincent was a co-founder and has been the Chief Executive Officer of Sarissa, Inc. since 2000. Dr. Vincent has extensive industry experience as a consultant to Canadian and US biotechnology and pharmaceutical companies. Previously, he served as a Director of Drug Royalty Corporation and currently is a member of the Scientific Advisory Boards for several biotechnology companies. Dr. Vincent is an Associate Professor of Oncology at the University of Western Ontario, and a staff medical oncologist at the London Regional Cancer Program.... read more

Biography PhotoBrad Thompson, Ph.D.
Board Member
Dr. Thompson is an experienced and respected biotechnology professional who has held the positions of Chairman of the Board and President and Chief Executive Officer of Oncolytics Biotech, Inc., a biotechnology company, since April 1999. Prior to his role with Oncolytics, Dr. Thompson was the Chief Executive Officer of Synsorb Biotech from 1994 to 1999. Dr. Thompson also is currently a Board member of Immunovaccine, Inc. He received his Ph.D. from the University of Western Ontario in the Department of Microbiology and Immunology.... read more